Skip to main content
Le Travenues Technology Limited logo

Le Travenues Technology Limited — Investor Relations & Filings

Ticker · IXIGO ISIN · INE0HV901016 LEI · 894500YYQ69FQ449KJ55 BSE.NS Administrative and support service activities
Open in API
Filings indexed 472 across all filing types
Latest filing 2024-11-19 Regulatory Filings
Country IN India
Listing BSE.NS IXIGO

About Le Travenues Technology Limited

https://www.ixigo.com

Le Travenues Technology Limited operates a digital platform specializing in travel planning and booking services. The company provides a suite of tools for flight, train, and bus reservations, integrating data from various service providers to enable price comparison and real-time availability tracking. Its core offerings include proprietary algorithms for fare prediction, automated check-in processes, and live status updates for transportation services. By utilizing artificial intelligence and machine learning, the platform delivers personalized travel recommendations and optimizes the booking experience for users. The company focuses on mobile-centric solutions to streamline itinerary management and enhance travel efficiency through data-driven insights.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an announcement addressed to stock exchanges regarding the schedule of an analyst/investor meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is a notification of an upcoming investor meeting, not a detailed investor presentation or financial report. The document length is short (1922 characters), and it serves as an announcement rather than the actual meeting materials or transcript. Therefore, it fits best under the category of Investor Presentation announcements or related disclosures. However, since it is only a schedule announcement and not the presentation itself, the closest fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-11-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an announcement addressed to stock exchanges (BSE and NSE) regarding the outcome of meetings with analysts and investors. It explicitly states that no unpublished price sensitive information was discussed. The document is short (2149 characters) and serves as a regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which pertains to material events and information. There is no financial data, report, or detailed presentation included, only a summary of the meetings held. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain financial statements or detailed report content.
2024-11-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an announcement addressed to stock exchanges regarding the schedule of analysts and investor meetings to be attended by company officials. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations for listed companies. The content is a forward-looking schedule and does not contain any financial statements, detailed financial data, or report content. The document length is 3430 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is a report itself, but rather an announcement of upcoming investor meetings. Therefore, this fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and disclosures that do not fit other specific categories.
2024-11-12 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India clarifying a previous submission of financial results for the quarter and half year ended September 30, 2024. It states that the financial results submitted on October 24, 2024, comply with SEBI regulations and were duly signed by auditors. The document is short (1750 characters) and serves as a clarification regarding a regulatory compliance issue rather than containing actual financial data or the financial report itself. It does not present the financial results but addresses a query about the format and auditor signature. Therefore, it is not an Interim/Quarterly Report (IR) or Annual Report (10-K), but rather a regulatory communication clarifying compliance. According to the rules, such a document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and clarifications that do not fit other categories.
2024-11-12 English
Options to purchase securities
Capital/Financing Update Classification · 95% confidence The document is an announcement made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details the grant of employee stock options under the company's ESOS 2024 scheme. The content includes specifics about the number of options granted, pricing, vesting schedule, and other terms related to the stock option grant. There are no financial statements, quarterly or annual results, or management discussion and analysis. The document is a regulatory disclosure about a capital-related event (grant of stock options) rather than a full financial report or earnings release. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as stock option grants.
2024-11-11 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a detailed statement regarding the deviation or variation in the utilization of funds raised through an Initial Public Offering (IPO) by Le Travenues Technology Limited for the quarter ended September 30, 2024. It includes a Monitoring Agency Report by ICRA Limited, comments from the Audit Committee, and detailed tables showing the allocation and utilization of funds. The document references compliance with SEBI regulations and provides a comprehensive review of the use of IPO proceeds, including progress updates and certifications. This type of document is a regulatory compliance report related to the use of IPO proceeds and monitoring agency findings, which fits best under the category of Regulatory Filings (RNS) as it is a regulatory announcement and compliance disclosure rather than a financial report like an Annual or Interim Report. It is not a full financial report but a regulatory compliance statement with monitoring agency commentary.
2024-11-07 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.